0000937556-19-000140.txt : 20190715
0000937556-19-000140.hdr.sgml : 20190715
20190715175609
ACCESSION NUMBER: 0000937556-19-000140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190711
FILED AS OF DATE: 20190715
DATE AS OF CHANGE: 20190715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yongsam
CENTRAL INDEX KEY: 0001403400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33642
FILM NUMBER: 19955910
MAIL ADDRESS:
STREET 1: C/O MASIMO CORPORATION
STREET 2: 40 PARKER
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASIMO CORP
CENTRAL INDEX KEY: 0000937556
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330368882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-297-7000
MAIL ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_156322775422327.xml
FORM 4
X0306
4
2019-07-11
0
0000937556
MASIMO CORP
MASI
0001403400
Lee Yongsam
C/O MASIMO CORPORATION
52 DISCOVERY
IRVINE
CA
92618
0
1
0
0
EVP & CIO
Common Stock
2019-07-11
4
M
0
5339
21.97
A
78339
D
Common Stock
2019-07-11
4
S
0
5339
151.3295
D
73000
D
Common Stock
2019-07-12
4
M
0
5989
21.97
A
78989
D
Common Stock
2019-07-12
4
S
0
5989
151.8345
D
73000
D
Common Stock
2019-07-15
4
M
0
1172
21.97
A
74172
D
Common Stock
2019-07-15
4
S
0
1172
153.9773
D
73000
D
Non-Qualified Stock Option (Right to Buy)
21.97
2019-07-11
4
M
0
5339
21.97
D
2014-05-28
2023-05-28
Common Stock
5339.0
12161
D
Non-Qualified Stock Option (Right to Buy)
21.97
2019-07-12
4
M
0
5989
21.97
D
2014-05-28
2023-05-28
Common Stock
5989.0
6172
D
Non-Qualified Stock Option (Right to Buy)
21.97
2019-07-15
4
M
0
1172
21.97
D
2014-05-28
2023-05-28
Common Stock
1172.0
5000
D
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 23, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $149.19 per share to a high of $152.705 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $150.56 per share to a high of $153.15 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $151.80 per share to a high of $154.905 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on May 28, 2013 and is exercisable as it vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
/s/ David J. Van Ramshorst - Attorney-in-Fact
2019-07-15